Update on amniotic membrane transplantation

Expert Review of Ophthalmology

Volumn 5, Issue 5, 2010, Pages 645-661

  Liu, Jingbo ^a,b   Sheha, Hosam ^a,c   Fu, Yao ^a,d   Liang, Lingyi ^e   Tseng, Scheffer C G ^a  

^a OCULAR SURFACE CENTER   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

amniotic membrane; cryopreservation; fibrosis; inflammation; ocular surface; reconstruction; regenerative medicine; tissue engineering; wound healing

Indexed keywords

MITOMYCIN C;

AMNION TRANSPLANTATION; CONJUNCTIVA TUMOR; CORNEA PERFORATION; CORNEA ULCER; CRYOPRESERVATION; EPITHELIUM; EPITHELIZATION; EX VIVO STUDY; EYE DISEASE; GLAUCOMA; HUMAN; INFECTION; KERATITIS; KERATOPATHY; NONHUMAN; PTERYGIUM; REGENERATIVE MEDICINE; REVIEW; STEM CELL; SYMBLEPHARON; TISSUE TRANSPLANTATION; TREATMENT INDICATION; WOUND HEALING;

EID: 77957929743     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.10.63     Document Type: Review

References (185)

1. Tseng SCG, Espana EM, Kawakita T et al. How does amniotic membrane work? Ocul. Surf. 2(3), 177-187 (2004)
2. Sippel KC, Ma JJK, Foster CS. Amniotic membrane surgery. Curr. Opin. Ophthalmol. 12, 269-281 (2001).
3. Tseng SCG. Amniotic membrane transplantation for ocular surface reconstruction. Bioscience Rep. 21, 481-489 (2002).
4. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49(1), 51-77 (2004).
5. Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocul. Surf. 2(3), 201-211 (2004).
6. Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Scarless wound healing in mammalian fetus. Surgery 174, 441-451 (1992).
7. Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann. Surg. 220, 10-18 (1994).
8. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp. Eye Res. 70(3), 329-337 (2000).
9. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20(4), 408-413 (2001).
10. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch. Ophthalmol. 126(8), 1059-1066 (2008).
11. Park WC, Tseng SC. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest. Ophthalmol. Vis. Sci. 41(10), 2906-2914 (2000).
12. Heiligenhaus A, Meller D, Meller D, Steuhl K-P, Tseng SCG. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42, 1969-1974 (2001).
13. Heiligenhaus A, Li H, Hernandez Galindo EE, Koch JM, Steuhl KP, Meller D. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation. Br. J. Ophthalmol. 87(10), 1215-1219 (2003).
14. Bauer D, Wasmuth S, Hermans P et al. On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation. Exp. Eye Res. 85(3), 335-345 (2007).
15. Bauer D, Wasmuth S, Hennig M, Baehler H, Steuhl KP, Heiligenhaus A. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 50(7), 3188-3198 (2009).
16. Li W, He H, Kawakita T, Espana EM, Tseng SCG. Amniotic membrane induces apoptosis of interferon-g activited macrophages in vitro. Exp. Eye Res. 82(2), 282-292 (2006).
17. He H, Li W, Chen SY et al. Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract. Invest. Ophthalmol. Vis. Sci. 49(10), 4468-4475 (2008).
18. He H, Li W, Tseng DY et al. Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-a-inhibitor (HC•HA) purified from extracts of human amniotic membrane. J. Biol. Chem. 284(30), 20136-20146 (2009).
19. Tseng SCG, Li D-Q, Ma X. Suppression of transforming growth factor isoforms, TGF-b receptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J. Cell. Physiol. 179, 325-335 (1999).
20. Lee S-B, Li D-Q, Tan DTH, Meller D, Tseng SCG. Suppression of TGF-b signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr. Eye Res. 20, 325-334 (2000).
21. Choi TH, Tseng SCG. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane. Cornea 20, 197-204 (2001).
22. Espana EM, He H, Kawakita T et al. Human keratocytes cultured on amniotic membrane stroma preserve morphology and express keratocan. Invest. Ophthalmol. Vis. Sci. 44(12), 5136-5141 (2003).
23. Espana EM, Kawakita T, Liu CY, Tseng SCG. CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-b1. Invest. Ophthalmol. Vis. Sci. 45(9), 2985-2991 (2004).
24. Kawakita T, Espana EM, He H et al. Keratocan expression of murine keratocytes is maintained on amniotic membrane by downregulating TGF-b signaling. J. Biol. Chem. 280, 27085-27092 (2005).
25. Kawakita T, Espana EM, He H et al. Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-b signaling in a low-calcium, serum-free medium. Invest. Ophthalmol. Vis. Sci. 47(5), 1918-1927 (2006).
26. Kim JC, Tseng SCG. The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J. Ophthalmol. 9, 32-46 (1995).
27. Jiang A, Li C, Gao Y et al. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization. Cornea 25(10 Suppl. 1), S36-S40 (2006).
28. Kucukerdonmez C, Akova YA, Altinors DD. Vascularization is more delayed in amniotic membrane graft than conjunctival autograft after pterygium excision. Am. J. Ophthalmol. 143(2), 245-249 (2007).
29. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membranetransplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. 116, 431-441 (1998).
30. Tsubota K, Satake Y, Kaido M et al. Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation. N. Eng. J. Med. 340, 1697-1703 (1999).
31. Tsai RJF, Li L-M, Chen J-K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Eng. J. Med. 343, 86-93 (2000).
32. Kobayashi N, Kabuyama Y, Sasaki S, Kato K, Homma Y. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 21(1), 62-67 (2002).
33. Stellmach V, Crawford SE, Zhou W, Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epitheliumderived factor. Proc. Natl Acad. Sci. USA 98(5), 2593-2597 (2001).
34. Shao C, Sima J, Zhang SX et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest. Ophthalmol. Vis. Sci. 45(6), 1758-1762 (2004).
35. Hao Y, Ma DH-K, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19, 348-352 (2000).
36. Ma DH, Yao JY, Yeh LK et al. In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 45(8), 2586-2595 (2004).
37. Sheha H, Liang L, Li J, Tseng SC. Sutureless amniotic membrane transplantation for severe bacterial keratitis. Cornea 28(10), 1118-1123 (2009).
38. John T, Foulks GN, John ME, Cheng K, Hu D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109(2), 351-360 (2002).
39. Kobayashi A, Yoshita T, Sugiyama K et al. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology 113(1), 126-132 (2006).
40. Sonmez B, Kim BT, Aldave AJ. Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential. Cornea 26(2), 227-229 (2007).
41. Finger PT. Finger's amniotic membrane buffer technique: protecting the cornea during radiation plaque therapy. Arch. Ophthalmol. 126(4), 531-534 (2008).
42. Ono K, Yokoo S, Mimura T et al. Autologous transplantation of conjunctival epithelial cells cultured on amniotic membrane in a rabbit model. Mol. Vis. 13, 1138-1143 (2007).
43. Tanioka H, Kawasaki S, Yamasaki K et al. Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. Invest. Ophthalmol. Vis. Sci. 47(9), 3820-3827 (2006).
44. Ang LP, Tan DT. Autologous cultivated conjunctival transplantation for recurrent viral papillomata. Am. J. Ophthalmol. 140(1), 136-138 (2005).
45. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell culture methods. Biosci. Rep. 23(4), 169-174 (2003).
46. Meller D, Dabul V, Tseng SC. Expansion of conjunctival epithelial progenitor cells on amniotic membrane. Exp. Eye Res. 74(4), 537-545 (2002).
47. Zakaria N, Koppen C, Van Tendeloo V, Berneman Z, Hopkinson A, Tassignon MJ. Standardized limbal epithelial stem cell graft generation and transplantation. Tissue Eng. Part C Methods DOI: 10.1089/ten. tec.2009.0634 (2010) (Epub ahead of print).
48. Lekhanont K, Choubtum L, Chuck RS, Sa-ngiampornpanit T, Chuckpaiwong V, Vongthongsri A. A serum- and feeder-free technique of culturing human corneal epithelial stem cells on amniotic membrane. Mol. Vis. 15, 1294-1302 (2009).
49. Kinoshita S, Nakamura T. Development of cultivated mucosal epithelial sheet transplantation for ocular surface reconstruction. Artif. Organs 28(1), 22-27 (2004). (Pubitemid 38234240)
50. Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, Quantock AJ. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest. Ophthalmol. Vis. Sci. 41(9), 2506-2513 (2000).
51. Baharvand H, Ebrahimi M, Javadi MA. Comparison of characteristics of cultured limbal cells on denuded amniotic membrane and fresh conjunctival, limbal and corneal tissues. Dev. Growth Differ. 49(3), 241-251 (2007).
52. Sudha B, Sitalakshmi G, Iyer GK, Krishnakumar S. Putative stem cell markers in limbal epithelial cells cultured on intact & denuded human amniotic membrane. Indian J. Med. Res. 128(2), 149-156 (2008).
53. Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19, 421-426 (2000).
54. Koizumi N, Cooper LJ, Fullwood NJ et al. An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest. Ophthalmol. Vis. Sci. 43(7), 2114-2121 (2002).
55. Meller D, Pires RTF, Tseng SCG. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures. Br. J. Ophthalmol. 86, 463-471 (2002).
56. Grueterich M, Tseng SCG. Human limbal progenitor cells expanded on intact amniotic membrane. Arch. Ophthalmol. 120, 783-790 (2002).
57. Grueterich M, Espana E, Tseng SC. Connexin 43 expression and proliferation of human limbal epithelium on intact and denuded amniotic membrane. Invest. Ophthalmol. Vis. Sci. 43(1), 63-71 (2002).
58. Ban Y, Cooper LJ, Fullwood NJ et al. Comparison of ultrastructure, tight junction-related protein expression and barrier function of human corneal epithelial cells cultivated on amniotic membrane with and without air-lifting. Exp. Eye Res. 76(6), 735-743 (2003).
59. Ramaesh K, Dhillon B. Ex vivo expansion of corneal limbal epithelial/stem cells for corneal surface reconstruction. Eur. J. Ophthalmol. 13(6), 515-524 (2003).
60. Madhira SL, Vemuganti G, Bhaduri A, Gaddipati S, Sangwan VS, Ghanekar Y. Culture and characterization of oral mucosal epithelial cells on human amniotic membrane for ocular surface reconstruction. Mol. Vis. 14, 189-196 (2008).
61. Nakamura T, Endo K, Cooper LJ et al. The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest. Ophthalmol. Vis. Sci. 44(1), 106-116 (2003).
62. Nakamura T, Inatomi T, Sotozono C, Amemiya T, Kanamura N, Kinoshita S. Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders. Br. J. Ophthalmol. 88(10), 1280.1284 (2004).
63. Wencan W, Mao Y, Wentao Y et al. Using basement membrane of human amniotic membrane as a cell carrier for cultivated cat corneal endothelial cell transplantation. Curr. Eye Res. 32(3), 199.215 (2007).
64. Ishino Y, Sano Y, Nakamura T et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest. Ophthalmol. Vis. Sci. 45(3), 800.806 (2004).
65. Chen YT, Li W, Hayashida Y et al. Human amniotic epithelial cells as novel feeder layers for promoting ex vivo expansion of limbal epithelial progenitor cells. Stem Cells 25(8), 1995.2005 (2007).
66. Koizumi N, Inatomi T, Quantock AJ, Fullwood NJ, Dota A, Kinoshita S. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 19, 65.71 (2000).
67. Nakamura T, Kinoshita S. Ocular surface reconstruction using cultivated mucosal epithelial stem cells. Cornea 22(7 Suppl.), S75.S80 (2003).
68. Song E, Yang W, Cui ZH et al. Transplantation of human limbal cells cultivated on amniotic membrane for reconstruction of rat corneal epithelium after alkaline burn. Chin. Med. J. (Engl.) 118(11), 927.935 (2005).
69. Espana EM, Ti SE, Grueterich M, Touhami A, Tseng SC. Corneal stromal changes following reconstruction by ex vivo expanded limbal epithelial cells in rabbits with total limbal stem cell deficiency. Br. J. Ophthalmol. 87(12), 1509.1514 (2003).
70. Nakamura T, Koizumi N, Tsuzuki M et al. Successful regrafting of cultivated corneal epithelium using amniotic membrane as a carrier in severe ocular surface disease. Cornea 22(1), 70.71 (2003).
71. Tan DT, Ang LP, Beuerman RW. Reconstruction of the ocular surface by transplantation of a serum-free derived cultivated conjunctival epithelial equivalent. Transplantation 77(11), 1729.1734 (2004).
72. Nakamura T, Inatomi T, Sotozono C, Koizumi N, Kinoshita S. Successful primary culture and autologous transplantation of corneal limbal epithelial cells from minimal biopsy for unilateral severe ocular surface disease. Acta Ophthalmol. Scand. 82(4), 468.471 (2004).
73. Lee S-H, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am. J. Ophthalmol. 123, 303.312 (1997).
74. Solomon A, Touhami A, Sandoval H, Tseng SCG. Neurotrophic keratopathy: basic concepts and therapeutic strategies. Comp. Ophthalmol. Update 3, 165.174 (2000).
75. Chen H-J, Pires RTF, Tseng SCG. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br. J. Ophthalmol. 84, 826.833 (2000).
76. Hanada K, Shimazaki J, Shimmura S, Tsubota K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am. J. Ophthalmol. 131(3), 324.331 (2001).
77. Solomon A, Meller D, Prabhasawat P et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 109(4), 694.703 (2002).
78. Letko E, Stechschulte SU, Kenyon KR et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch. Ophthalmol. 119, 659.663 (2001).
79. Rodriguez-Ares MT, Tourino R, Lopez.Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea 23(6), 577.583 (2004).
80. Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24(4), 369.377 (2005).
81. Seitz B, Das S, Sauer R, Mena D, Hofmann- Rummelt C. Amniotic membrane transplantation for persistent corneal epithelial defects in eyes after penetrating keratoplasty. Eye 23(4), 840.848 (2009).
82. Nubile M, Dua HS, Lanzini TE et al. Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study. Br. J. Ophthalmol. 92(1), 54.60 (2008).
83. Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br. J. Ophthalmol. 85(12), 1455.1463 (2001).
84. Duchesne B, Tahi H, Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea 20(2), 230.232 (2001).
85. Kim HK, Park HS. Fibrin glue-assisted augmented amniotic membrane transplantation for the treatment of large noninfectious corneal perforations. Cornea 28(2), 170.176 (2009).
86. Kim JS, Kim JC, Hahn TW, Park WC. Amniotic membrane transplantation in infectious corneal ulcer. Cornea 20(7), 720.726 (2001).
87. Gicquel JJ, Bejjani RA, Ellies P, Mercie M, Dighiero P. Amniotic membrane transplantation in severe bacterial keratitis. Cornea 26(1), 27.33 (2007).
88. Mencucci R, Menchini U, Dei R. Antimicrobial activity of antibiotictreated amniotic membrane: an in vitro study. Cornea 25(4), 428.431 (2006).
89. Pires RTF, Tseng SCG, Prabhasawat P et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch. Ophthalmol. 117, 1291.1297 (1999).
90. Mrukwa-Kominek E, Gierek-Ciaciura S, Rokita-Wala I, Szymkowiak M. [Use of amniotic membrane transplantation for treating bullous keratopathy]. Klin. Oczna 104(1), 41.46 (2002).
91. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea 21(4), 342.345 (2002).
92. Espana EM, Grueterich M, Sandoval HkqbZ;kW et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J. Cat. Refract. Surg. 29, 279.284 (2003).
93. Chansanti O, Horatanaruang O. The results of amniotic membrane transplantation for symptomatic bullous keratopathy. J. Med. Assoc. Thai. 88(Suppl. 9), S57.S62 (2005).
94. Di Pascuale MA, Espana EM, Liu DT et al. Correlation of corneal complications with eyelipid cicatricial pathologies in patients with Steven Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5), 904.912 (2005).
95. Muqit MM, Ellingham RB, Daniel C. Technique of amniotic membrane transplant dressing in the management of acute Stevens.Johnson syndrome. Br. J. Ophthalmol. 91(11), 1536 (2007).
96. Tandon A, Cackett P, Mulvihill A, Fleck B. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis. J. AAPOS 11(6), 612-613 (2007).
97. Shammas MC, Lai EC, Sarkar JS, Yang J, Starr CE, Sippel KC. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids. Am. J. Ophthalmol. 149(2), 203-213 (2010).
98. Gregory DG. The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul. Surf. 6(2), 87-95 (2008).
99. Shay E, Kheirkhah A, Liang L, Sheha H, Gregory DG, Tseng SC. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. Surv. Ophthalmol. 54(6), 686-696 (2009).
100. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp. Eye Res. 78(3), 433-446 (2004).
101. Dua HS, Jagjit SS, Azuara-Blanco A, Gupta P. Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J. Ophthalmol. 48, 83-92 (2000).
102. Anderson DF, Ellies P, Pires RT, Tseng SC. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br. J. Ophthalmol. 85(5), 567-575 (2001). (Pubitemid 32397833)
103. Gomes JA, dos Santos MS, Cunha MC, Mascaro VL, Barros JN, de Sousa LB. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 110(3), 466-473 (2003).
104. Sangwan VS, Matalia HP, Vemuganti GK, Rao GN. Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency. Indian J. Ophthalmol. 52(4), 281-285 (2004).
105. Dua HS. The conjunctiva in corneal epithelial wound healing. Br. J. Ophthalmol. 82, 1407-1411 (1998).
106. Kheirkhah A, Casas V, Raju VK, Tseng SC. Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency. Am. J. Ophthalmol. 145(5), 787-794 (2008).
107. Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5), 709-722 (1989).
108. Tan D. Conjunctival grafting for ocular surface disease. Curr. Opin. Ophthalmol. 10, 277-281 (1999).
109. Basti S, Rao SK. Current status of limbal conjunctival autograft. Curr. Opin. Ophthalmol. 11(4), 224-232 (2000).
110. Kruse FE, Reinhard T. [Limbus transplantation for reconstruction of the ocular surface]. Ophthalmologe 98(9), 818-831 (2001). (Pubitemid 32905029)
111. Gruterich M, Tseng SC. [Surgical approaches for limbal stem cell deficiency]. Klin. Monatsbl. Augenheilkd. 219(5), 333-339 (2002).
112. Liang L, Sheha H, Li J, Tseng SC. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond.) 23(10), 1946-1953 (2009).
113. Meallet MA, Espana EM, Grueterich M, Ti S-E, Goto E, Tseng SCG. Amniotic membrane transplantation for recipient and donor eyes undergoing conjunctival limbal autograft for total limbal stem cell deficiency. Ophthalmology 110, 1585-1592 (2003).
114. Ivekovic R, Tedeschi-Reiner E, Novak-Laus K, Ndrijevic-Derk B, Cima I, Mandic Z. Limbal graft and/or amniotic membrane transplantation in the treatment of ocular burns. Ophthalmologica 219(5), 297-302 (2005).
115. Santos MS, Gomes JA, Hofling-Lima AL, Rizzo LV, Romano AC, Belfort R Jr. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am. J. Ophthalmol. 140(2), 223-230 (2005).
116. Kheirkhah A, Raju VK, Tseng SC. Minimal conjunctival limbal autograft for total limbal stem cell deficiency. Cornea 27(6), 730-733 (2008).
117. Liang L, Sheha H, Tseng SC. Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Arch. Ophthalmol. 127(11), 1428-1434 (2009).
118. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br. J. Ophthalmol. 86(6), 640-645 (2002).
119. Solomon A, Espana EM, Tseng SCG. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110, 93-100 (2003). (Pubitemid 36068732)
120. Tseng SCG, Prabhasawat P, Lee S-H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am. J. Ophthalmol. 124, 765-774 (1997).
121. Jain AK, Bansal R, Sukhija J. Human amniotic membrane transplantation with fibrin glue in management of primary pterygia: a new tuck-in technique. Cornea 27(1), 94-99 (2008).
122. Essex RW, Snibson GR, Daniell M, Tole DM. Amniotic membrane grafting in the surgical management of primary pterygium. Clin. Experiment. Ophthalmol. 32(5), 501-504 (2004).
123. Fallah MR, Golabdar MR, Amozadeh J, Zare MA, Moghimi S, Fakhraee G. Transplantation of conjunctival limbal autograft and amniotic membrane vs mitomycin C and amniotic membrane in treatment of recurrent pterygium. Eye 22(3), 420-424 (2008).
124. Luanratanakorn P, Ratanapakorn T, Suwan-Apichon O, Chuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br. J. Ophthalmol. 90(12), 1476-1480 (2006).
125. Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr. Opin. Ophthalmol. 13(4), 204-212 (2002).
126. Kheirkhah A, Casas V, Sheha H, Raju VK, Tseng SCG. Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium. Cornea 27(1), 56-63 (2008).
127. Barraquer JI. Etiology, pathogenesis, and treatment of the pterygium. In: Transactions of the New Orleans Academy of Ophthalmology, Symposium on Medical and Surgical Diseases of the Cornea. CV Mosby, MO, USA, 167-178 (1980).
128. Prabhasawat P, Barton K, Burkett G, Tseng SCG. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 104, 974-985 (1997).
129. Hirst LW. Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology 116(7), 1278-1286 (2009).
130. Kaufman HE, Thomas EL. Prevention and treatment of symblepharon. Am. J. Ophthalmol. 88(3 Pt 1), 419-423 (1979).
131. Ballen PH. Mucous membrane grafts in chemical (lye) burns. Am. J. Ophthalmol. 55, 302.312 (1963).
132. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br. J. Ophthalmol. 82, 235.240 (1998).
133. Jain S, Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye 18(12), 1251.1257 (2004).
134. Tseng SCG, Di Pascuale MA, Liu D-Z, Gao Y-Y, Baradaran-Rafii A. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112, 896.903 (2005).
135. Zhou SY, Chen JQ, Chen LS, Liu ZG, Huang T, Wang ZC. [Long-term results of amniotic membrane transplantation for conjunctival surface reconstruction]. Zhonghua Yan. Ke. Za Zhi. 40(11), 745.749 (2004).
136. Patel BC, Sapp NA, Collin R. Standardized range of conformers and symblepharon rings. Ophthal. Plast. Reconstr. Surg. 14(2), 144.145 (1998).
137. Choy AE, Asbell RL, Taterka HB. Symblepharon repair using a silicone sheet implant. Ann. Ophthalmol. 9(2), 197.204 (1977).
138. Ralph RA. Reconstruction of conjunctival fornices using silicone rubber sheets. Ophthalmic Surg. 6(3), 55.57 (1975).
139. Fein W. Repair of total and subtotal symblepharons. Ophthalmic Surg. 10(6), 44.47 (1979).
140. Nava-Castaneda A, Tovila-Canales JL, Monroy-Serrano MH et al. [Comparative study of amniotic membrane transplantation, with and without simultaneous application of mitomycin C in conjunctival fornix reconstruction]. Arch. Soc. Esp. Oftalmol. 80(6), 345.352 (2005).
141. Kheirkhah A, Blanco G, Casas V, Hayashida Y, Raju VK, Tseng SC. Surgical strategies for fornix reconstruction based on symblepharon severity. Am. J. Ophthalmol. 146(2), 266.275 (2008).
142. Meller D, Tseng SCG. Conjunctivochalasis: literature review and possible pathophysiology. Surv. Ophthalmol. 43, 225.232 (1998).
143. Di Pascuale MA, Espana EM, Kawakita T, Tseng SC. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br. J. Ophthalmol. 88(3), 388.392 (2004).
144. Meller D, Maskin SL, Pires RTF, Tseng SCG. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea 19, 796.803 (2000).
145. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved amniotic membrane. Cornea 20, 619.621 (2001).
146. Kheirkhah A, Casas V, Blanco G et al. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am. J. Ophthalmol. 144(2), 311.313 (2007).
147. Kheirkhah A, Casas V, Esquenazi S et al. New surgical approach for superior conjunctivochalasis. Cornea 26(6), 685.691 (2007).
148. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch. Ophthalmol. 115, 1360.1367 (1997).
149. Paridaens D, Beekhuis H, van Den Bosch W, Remeyer L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br. J. Ophthalmol. 85, 658.661 (2001).
150. Chen Z, Yan J, Yang H et al. Amniotic membrane transplantation for conjunctival tumor. Yan. Ke. Xue. Bao. 19(3), 165.167, 145 (2003).
151. Dalla PG, Ghirlando A, Busato F, Midena E. Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: a long-term study. Eur. J. Ophthalmol. 15(4), 446.450 (2005).
152. Rodriguez-Ares MT, Tourino R, Capeans C, Sanchez-Salorio M. Repair of scleral perforation with preserved scleral amniotic membrane in Marfan's syndrome. Ophthalmic Surg. Lasers 30, 485.487 (1999).
153. Casas V, Kheirkhah A, Blanco G, Tseng SC. Surgical approach for scleral ischemia and melt. Cornea 27(2), 196.201 (2008).
154. Sheha H, Liang L, Tseng SCG. Amniotic membrane grafts for glaucoma surgery. In: The Glaucoma Book: a Practical, Evidence- Based Approach to Patient Care. Schacknow PN, Samples JR (Eds). Springer, Berlin, Germany, 861.869 (2010).
155. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrolled glaucoma. Ophthalmic Surg. Lasers 29, 428.431 (1998).
156. Lu H, Mai D. [Trabeculectomy combined amniotic membrane transplantation for refractory glaucoma]. Yan. Ke. Xue. Bao. 19(2), 89.91 (2003).
157. Yue J, Hu CQ, Lei XM, Qin GH, Zhang Y. [Trabeculectomy with amniotic membrane transplantation and combining suture lysis of scleral flap in complicated glaucoma]. Zhonghua Yan. Ke. Za Zhi. 39(8), 476.480 (2003).
158. Drolsum L, Willoch C, Nicolaissen B. Use of amniotic membrane as an adjuvant in refractory glaucoma. Acta Ophthalmol. Scand. 84(6), 786.789 (2006).
159. Sheha H, Kheirkhah A, Taha H. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma. J. Glaucoma. 17(4), 303.307 (2008).
160. Bruno CA, Eisengart JA, Radenbaugh PA, Moroi SE. Subconjunctival placement of human amniotic membrane during high risk glaucoma filtration surgery. Ophthalmic Surg. Lasers Imaging 37(3), 190.197 (2006).
161. Eliezer RN, Kasahara N, Caixeta.Umbelino C, Pinheiro RK, Mandia C Jr, Malta RF. Use of amniotic membrane in trabeculectomy for the treatment of glaucoma: a pilot study. Arq. Bras. Oftalmol. 69(3), 309.312 (2006).
162. Zheng K, Huang Z, Zou H, Li H, Huang Y, Xie M. [The comparison study of glaucoma trabeculectomy applying amniotic membrane or mitomycin C]. Yan. Ke. Xue. Bao. 21(2), 84.87, 91 (2005).
163. Zhong Y, Zhou Y, Wang K. [Effect of amniotic membrane on filtering bleb after trabeculectomy in rabbit eyes]. Yan. Ke. Xue. Bao. 16(2), 73.76, 83 (2000).
164. Barton K, Budenz D, Khaw PT, Tseng SCG. Glaucoma filtration surgery using amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42, 1762.1768 (2001).
165. Demir T, Turgut B, Akyol N, Ozercan I, Ulas F, Celiker U. Effects of amniotic membrane transplantation and mitomycin C on wound healing in experimental glaucoma surgery. Ophthalmologica 216(6), 438.442 (2002).
166. Wang L, Liu X, Zhang P, Lin J. [An experimental trial of glaucoma filtering surgery with amniotic membrane]. Yan. Ke. Xue. Bao. 21(2), 126.131 (2005).
167. Budenz DL, Barton K, Tseng SCG. Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am. J. Ophthalmol. 130, 580-588 (2000).
168. Kee C, Hwang JM. Amniotic membrane graft for late-onset glaucoma filtering leaks. Am. J. Ophthalmol. 133(6), 834-835 (2002).
169. Kiuchi T, Okamoto H, Ishii K, Oshika T. Amniotic membrane transplantation for late-onset bleb leakage with scleritis. Jpn. J. Ophthalmol. 49(1), 56-58 (2005).
170. Rauscher FM, Barton K, Budenz DL, Feuer WJ, Tseng SC. Long-term outcomes of amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am. J. Ophthalmol. 143(6), 1052-1054 (2007).
171. Nagai-Kusuhara A, Nakamura M, Fujioka M, Negi A. Long-term results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes Arch. Clin. Exp. Ophthalmol. 246(4), 567-571 (2008).
172. Fantes F, Palmberg PF. Late complications of glaucoma surgery. In: Glaucoma: Color Atlas and Synopsis of Clinical Ophthalmology. Rhee DJ, Rapuano CJ (Eds). McGraw-Hill Professional, NY, USA, 338-363 (2003).
173. Skuta GL, Beeson CC, Higginbotham EJ et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 99(3), 438-444 (1992).
174. Ma DH-K, See L-C, Liau S-B, Tsai RJF. Amniotic memrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br. J. Ophthalmol. 84, 973-978 (2000).
175. Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108, 449-460 (2001).
176. Francis BA, Du LT, Najafi K et al. Histopathologic features of conjunctival filtering blebs. Arch. Ophthalmol. 123(2), 166-170 (2005).
177. Ainsworth G, Rotchford A, Dua HS, King AJ. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br. J. Ophthalmol. 90(4), 417-419 (2006).
178. Rai P, Lauande-Pimentel R, Barton K. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am. J. Ophthalmol. 140(6), 1148-1152 (2005).
179. Papadaki TG, Siganos CS, Zacharopoulos IP, Panteleontidis V, Charissis SK. Human amniotic membrane transplantation for tube exposure after glaucoma drainage device implantation. J. Glaucoma 16(1), 171-172 (2007).
180. Mocan MC, Azar NF. Amniotic membrane transplantation for the repair of severe conjunctival dehiscence after strabismus surgery with adjustable sutures. Am. J. Ophthalmol. 140(3), 533-534 (2005).
181. Yamada M, Shinoda K, Hatakeyama A, Nishina S, Mashima Y. Fat adherence syndrome after retinal surgery treated with amniotic membrane transplantation. Am. J. Ophthalmol. 132, 280-282 (2001).
182. Sheha H, Casas V, Hayashida Y. The use of amniotic membrane in reducing adhesions after strabismus surgery. J. AAPOS 13(1), 99-101 (2009).
183. Marangon FB, Alfonso EC, Miller D, Remonda NM, Muallem MS, Tseng SCG. Incidence of microbial infection after amniotic membrane transplantation. Cornea 23, 264-269 (2004).
184. Kim JC, Lee D, Shyn KH. Clinical uses of human amniotic membrane for ocular surface diseases. In: Advances in Corneal Research. Lass JH (Ed.). Plenum Press, NY, USA, 117-134 (1997).
185. Gabler B, Lohmann CP. Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. Ophthalmology 107, 1344-1346 (2000).